Fate Therapeutics, Inc. (FATE)

NASDAQ: FATE · Real-Time Price · USD

1.040

+0.010 (0.97%)

At close: May 9, 2025, 4:00 PM

1.100

+0.060 (5.77%)

After-hours: May 9, 2025, 7:44 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Cellular Immunotherapies	63.53M	Log In	Log In	Log In	Log In	Upgrade
Cellular Immunotherapies Growth	-34.03%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	63.53M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-34.03%	Log In	Log In	Log In	Log In	Upgrade